<DOC>
	<DOCNO>NCT00238485</DOCNO>
	<brief_summary>This extension study design investigate long-term safety tolerability licarbazepine 750-2000 mg/d 52 week patient complete 6-week double-blind study CLIC477D2302 .</brief_summary>
	<brief_title>An Open-label Extension Study Evaluate Safety Tolerability Licarbazepine 750-2000 mg/d Treatment Manic Episodes Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<criteria>write informed consent provide prior participation extension study . successful completion study CLIC477D2302 willingness ability comply study requirement premature discontinuation study CLIC477D2302 failure comply study CLIC477D2302 protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bipolar I Disorder</keyword>
</DOC>